CLL is characterized by progressive accumulation of monoclonal B-lymphocytes expressing CD5 and CD23 molecules and characteristic low amounts of surface membrane Ig and CD79b molecules (133). Here, CD5 is linked to B-cell chronic lymphocytic leukemia.